Gastein health conference gets underway

The European Health Forum Gastein has commenced its four-day health conference, as President Clemens Martin Auer urged for increased action on pressing health issues such as rare diseases and cancer. The health committee expressed concern over controversial language regarding alcohol consumption in a recent report, which states that there is no safe level of alcohol intake for cancer prevention. The European Federation of Pharmaceutical Industries and Associations (EFPIA) sponsored the conference.

Auer highlighted the European Union's struggles with implementing health policies effectively, emphasizing that the lack of action is the primary issue hindering progress. He pointed out that global uncertainty has led to increased pharmaceutical investment in China due to the U.S.'s imposition of up to 100% tariffs on pharmaceuticals and their ingredients. Auer suggested that European countries should be willing to pay more for generic products to ensure a stable supply chain.

The conference also addressed the importance of health security and intelligence sharing between the defense and health sectors to counteract threats, such as cyberattacks and drones. Auer stressed the need for the health sector to be open to adopting security measures. The political advertisement highlighted the EU Biotech Act.

Furthermore, lawmakers in the public health committee adopted a report on cancer, advocating for dedicated funding, prevention measures, and equal access to cancer screening, diagnosis, and treatment across the EU. The report faced controversy due to its stance on alcohol consumption, which was deemed misleading. Additionally, MEPs called for a dedicated law to improve rare disease diagnosis, treatment, and patient care.